The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
about
Prognostic gene signatures for non-small-cell lung cancer.Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer PrognosisSparse group penalized integrative analysis of multiple cancer prognosis datasets.Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysisGenomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancerValidation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysisImpact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patientsOverexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.Identifying and Assessing Interesting Subgroups in a Heterogeneous Population.Improving referral of patients for consideration of adjuvant chemotherapy after surgical resection of lung cancer.Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancerReversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivoInnovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer.Visceral pleural invasion in lung adenocarcinoma ≤3 cm with ground-glass opacity: a clinical, pathological and radiological study.Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaAn individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.Adaptive prediction model in prospective molecular signature-based clinical studies.Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection.Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles.
P2860
Q30485836-6B5F2887-5BA8-4665-9E66-D0618BD2E3F7Q33772555-D7DEA2DF-9C78-4583-B157-F6A58899EF4AQ33876092-556E54A5-7575-4BB1-90E1-79F3121F686BQ33988433-60E1E57B-BFB2-4FA5-873E-02D2FB817AD8Q34212175-4D9142F6-B3D3-441A-A46A-F3BCD8971AB8Q34322495-F82F9741-8AC0-48E3-872D-164768504C7AQ34743874-AFC9A5A4-2C9A-4EEB-A750-A84143722DF5Q34814723-0F71E136-1752-4E09-8A75-C8265563D8DEQ34941004-7D93E8AB-DE50-4D65-AB22-3A29E2D9CCEAQ35074232-F7CE417D-5198-467E-9E0B-00F320CFA233Q35196367-B9D02B1A-96B0-481D-956F-EDD79C786AEEQ35646176-9A454845-3736-4670-B9E4-288EE58D9F19Q35963234-7D8FE64B-C32B-48C6-96E8-4410ADCA7AF1Q36416261-22B5E1B8-220E-4E29-AC1C-09AA94A16072Q36844877-B7C32F91-995C-425E-899B-D3B3A9AB05B0Q36851857-999720C4-AADA-4712-B488-7D3060315F8DQ37033306-B169803C-979B-41EE-88F7-85A78D9CA359Q37121512-D5F6A42E-B9E0-4AE8-9B7C-5289F079445FQ37217748-71827359-6152-4DE0-A496-F3864BC494A5Q37325311-67F190D1-A132-4D3D-8A56-8ABDB01AF076Q39180729-537A62ED-DBAC-49BF-A13B-514F09C3848EQ39297978-C212F8E0-2165-4E5C-A8C4-FDB5486020B5Q47130427-09096B6F-7569-44A5-9F94-86D046305B6BQ53681649-80B068D4-F146-445C-99CE-2F5A7AC8256C
P2860
The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The present status of postoper ...... ed non-small cell lung cancer.
@ast
The present status of postoper ...... ed non-small cell lung cancer.
@en
The present status of postoper ...... ed non-small cell lung cancer.
@nl
type
label
The present status of postoper ...... ed non-small cell lung cancer.
@ast
The present status of postoper ...... ed non-small cell lung cancer.
@en
The present status of postoper ...... ed non-small cell lung cancer.
@nl
prefLabel
The present status of postoper ...... ed non-small cell lung cancer.
@ast
The present status of postoper ...... ed non-small cell lung cancer.
@en
The present status of postoper ...... ed non-small cell lung cancer.
@nl
P2093
P1476
The present status of postoper ...... ted non-small cell lung cancer
@en
P2093
Harubumi Kato
Hisashi Saji
Jitsuo Usuda
Kuniharu Miyajima
Masahiro Tsuboi
Naohiro Kajiwara
Osamu Uchida
Tatsuo Ohira
P577
2007-04-01T00:00:00Z